At the heart of Addison Avery is Jenna Arnold, a seasoned global regulatory affairs expert with over 25 years of experience guiding pharmaceutical innovation from concept to market. With a proven track record leading global strategy, operations, and project management across every phase of drug development spanning oncology, neurology, rare diseases, and more. Jenna brings a hands-on, collaborative approach rooted in integrity, precision, and results.

Jenna has successfully led global regulatory strategies for leading pharmaceutical companies, working closely with health authorities across the U.S., EU, Latin America, and Asia-Pacific. Her ability to navigate complex regulatory landscapes, while fostering strong cross-functional relationships, makes her a trusted partner in accelerating drug development and ensuring compliance at every step.

In addition to her regulatory leadership, Jenna has excelled in regulatory project management, known for building and managing detailed project plans, dashboards, and timelines to drive efficient, compliant submissions and global study startups, she has consistently demonstrated her ability to bring together cross-functional teams, align stakeholders, and proactively mitigate risks—ensuring high-quality deliverables that meet both corporate and regulatory goals. Her project management acumen has been critical in navigating complex regulatory pathways and ensuring seamless execution of strategic initiatives.

“My mission is simple: to help life science companies bring therapies to patients faster, smarter, and with confidence—all while maintaining the highest standards of quality, transparency, and global alignment.” - Jenna